ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 259 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $22,224,000 | +87.1% | 239,119 | +19.9% | 1.41% | +62.2% |
| Q3 2021 | $11,875,000 | -41.6% | 199,410 | -33.1% | 0.87% | -32.1% |
| Q2 2021 | $20,340,000 | -10.6% | 298,247 | -9.1% | 1.28% | -19.5% |
| Q1 2021 | $22,756,000 | +7.1% | 327,942 | +18.5% | 1.59% | -3.4% |
| Q4 2020 | $21,254,000 | +343.9% | 276,633 | +151.9% | 1.64% | +387.2% |
| Q2 2018 | $4,788,000 | -12.4% | 109,811 | -20.6% | 0.34% | -13.8% |
| Q1 2018 | $5,466,000 | – | 138,378 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 252,500 | $11,320,000 | 4.95% |
| Rubric Capital Management LP | 857,103 | $38,424,000 | 3.59% |
| PFM Health Sciences, LP | 3,255,230 | $145,932,000 | 3.22% |
| Partner Investment Management, L.P. | 40,605 | $1,820,000 | 2.10% |
| DAFNA Capital Management LLC | 93,942 | $4,211,000 | 1.82% |
| Atika Capital Management LLC | 195,000 | $8,742,000 | 1.78% |
| Perceptive Advisors | 1,400,171 | $62,770,000 | 1.77% |
| EMORY UNIVERSITY | 47,779 | $2,142,000 | 1.51% |
| Rhenman & Partners Asset Management AB | 234,558 | $10,515,000 | 1.23% |
| Eversept Partners, LP | 75,721 | $3,394,572 | 0.99% |